Estrogen Replacement Therapy Induces Antioxidant and Longevity-Related Genes in Women after Medically Induced Menopause

• Published in: Oxidative medicine and cellular longevity 2021, Vol.2021 (1), p.8101615-8101615
• Main Authors: Borrás, C., Ferrando, M., Inglés, M., Gambini, J., Lopez-Grueso, R., Edo, R., Mas-Bargues, C., Pellicer, A., Viña, J.
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Anticoagulants; Antioxidants; Antioxidants - metabolism; Cell division; Estradiol - administration & dosage; Estrogen Replacement Therapy - methods; Estrogens; Estrogens - blood; Female; Gene expression; Glutathione - blood; Glutathione Peroxidase - genetics; Glutathione Peroxidase - metabolism; Humans; Infertility; Laboratories; Leukocytes, Mononuclear - cytology; Leukocytes, Mononuclear - drug effects; Leukocytes, Mononuclear - metabolism; Life expectancy; Longevity - genetics; Males; Menopause; Menopause - drug effects; Oxidative stress; Progesterone - blood; RNA, Ribosomal, 16S - genetics; RNA, Ribosomal, 16S - metabolism; Superoxide Dismutase - genetics; Superoxide Dismutase - metabolism; Telomeric Repeat Binding Protein 2 - genetics; Telomeric Repeat Binding Protein 2 - metabolism; Triptorelin Pamoate - pharmacology; Up-Regulation - drug effects; Womens health; Young Adult
• ISSN: 1942-0900; 1942-0994
• DOI: 10.1155/2021/8101615

Females live longer than males in many species, including humans, and estrogens are in part responsible for this protection against aging. We reported previously that estrogens can protect rats against oxidative stress, by inducing antioxidant and longevity-related genes. Thus, this study was aimed at confirming the ability of estrogens to upregulate antioxidant and longevity-related genes in humans. For this purpose, we selected 16 women of reproductive age (18-42 years old) undergoing a fertility treatment that includes a medically induced menopause, at the Valencian Infertility Institute. We took blood samples at each time point of the treatment (basal, induced menopause, estrogen, and estrogen plus progesterone replacement therapy). mRNA expression of antioxidant and longevity-related genes in peripheral blood mononuclear cells (PBMC) was determined by real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Determination of reduced glutathione (GSH) in total blood was carried out using high-performance liquid chromatography (HPLC). As expected, we found that medically induced menopause significantly decreased sexual hormone (estrogens and progesterone) levels. It also lowered glutathione peroxidase (GPx), 16S rRNA, P21, and TERF2 mRNA expression and blood GSH levels. Estrogen replacement therapy significantly restored estrogen levels and induced mRNA expression of manganese superoxide dismutase (MnSOD), GPx, 16S rRNA, P53, P21, and TERF2 and restored blood GSH levels. Progesterone replacement therapy induced a significant increase in MnSOD, P53, sestrin 2 (SENS2), and TERF2 mRNA expression when compared to basal conditions. These findings provide evidence for estrogen beneficial effects in upregulating antioxidant and longevity-related genes in women.